Home/Avocet Bio/Maximilian Strunz
MS

Maximilian Strunz

Chief Strategy Officer

Avocet Bio

Therapeutic Areas

Avocet Bio Pipeline

DrugIndicationPhase
CRISPR/Cas13 Antiviral PlatformBroad-spectrum RNA virus infections (e.g., Coronaviruses)Pre-clinical